Primary study · included by 1 review

Low bleeding and thromboembolic risk with continued dabigatran during cardiovascular interventions: the GLORIA-AF study.

van der Wall 2021 · van der Wall Sake J, Lip Gregory Y H, Teutsch Christine, et al. · European journal of internal medicine · 2021

Included by

Continuous vs interrupted direct oral anticoagulants for minimal bleeding-risk surgical procedures-a systematic review and meta-analysis.
Non-Cochrane · intervention · 2026 · cited as van der Wall 2021 · Table 1; References 12, 20-42

The review does not say which of its outcomes this study informs.

1 including review in total.